Sol-Generating Chemical Vapor into Liquid (SG-CViL) deposition – a facile method for encapsulation of diverse cell types in silica matrices. Issue 6 (12th December 2014)

• Record Type: Journal Article
• Authors: Johnston, Robert; Rogelj, Snezna; Harper, Jason C.; Tartis, Michaelann
• Is Part Of: Journal of materials chemistry. Volume 3:Issue 6(2015)
• Page Start: 1032
• Page End: 1041
• Publication Date: 2014-12-12
• Subjects: Materials -- Periodicals; Chemistry, Analytic -- Periodicals; Biomedical materials -- Research -- Periodicals; 543.0284
• DOI: 10.1039/c4tb01349b
• Languages: English
• ISSNs: 2050-750X

Abstract

Abstract : Silica sols are generated via deposition of tetramethyl orthosilicate into an aqueous medium. Subsequent mixing, under various experimental conditions, of eukaryotic and mammalian cell types with silica sols results in encapsulation of cells in tunable silica structures (green fluorescence). Abstract : In nature, cells perform a variety of complex functions such as sensing, catalysis, and energy conversion which hold great potential for biotechnological device construction. However, cellular sensitivity to ex vivo environments necessitates development of bio–nano interfaces which allow integration of cells into devices and maintain their desired functionality. In order to develop such an interface, the use of a novel Sol-Generating Chemical Vapor into Liquid (SG-CViL) deposition process for whole cell encapsulation in silica was explored. In SG-CViL, the high vapor pressure of tetramethyl orthosilicate (TMOS) is utilized to deliver silica into an aqueous medium, creating a silica sol. Cells are then mixed with the resulting silica sol, facilitating encapsulation of cells in silica while minimizing cell contact with the cytotoxic products of silica generating reactions ( i.e. methanol), and reduce exposure of cells to compressive stresses induced from silica condensation reactions. Using SG-CVIL, Saccharomyces cerevisiae ( S. cerevisiae ) engineered with an inducible beta galactosidase system were encapsulated in silica solids and remained both viable and responsive 29 days post encapsulation. By tuning SG-CViL parameters, thin layer silica deposition on mammalian HeLa and U87 human cancer cells was also achieved. The ability to encapsulate various cell types in either a multi cell ( S. cerevisiae ) or a thin layer (HeLa and U87 cells) fashion shows the promise of SG-CViL as an encapsulation strategy for generating cell–silica constructs with diverse functions for incorporation into devices for sensing, bioelectronics, biocatalysis, and biofuel applications.